Asia-Pacific Ophthalmology Lasers Market, By Product (Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, and Others), Type (Photodisruption Lasers, Selective Laser Trabeculoplasty (SLT), and Photocoagulation Lasers), Application (Diagnostics and Therapeutics), Gases (Noble Gas, Halogen Gas, Buffer Gas, and Others), End User (Hospitals, Clinics, and Others) - Industry Trends and Forecast to 2030.
Asia-Pacific Ophthalmology Lasers Market Analysis and Insights
The Asia-Pacific ophthalmology lasers market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.6% in the forecast period of 2023 to 2030 and is expected to reach USD 624.32 million by 2030 from USD 403.90 million in 2022.
This ophthalmology lasers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ophthalmology lasers market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product (Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, and Others), Type (Photodisruption Lasers, Selective Laser Trabeculoplasty (SLT), and Photocoagulation Lasers), Application (Diagnostics and Therapeutics), Gases (Noble Gas, Halogen Gas, Buffer Gas, and Others), End User (Hospitals, Clinics, and Others)
|
|
Countries Covered
|
Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and the Rest of Asia-Pacific
|
|
Market Players Covered
|
NIDEK CO., LTD., Quantel Medical (Subsidiary of Lumibird Medical), Aurolab, Alcon, Ziemer Ophthalmic Systems AG, LIGHTMED, Johnson & Johnson Inc., Bausch & Lomb Incorporated, MEDA Co., Ltd., Topcon, Lumenis Be Ltd., IRIDEX Corporation, and Zeiss among others
|
Market Definition
Ophthalmology lasers are specialized medical devices that emit focused beams of light to treat various eye conditions. These lasers are commonly used in ophthalmology to perform various procedures, such as treating vision disorders, correcting refractive errors, and managing various eye diseases. The devices gained increased importance and adoption due to the high prevalence of several ophthalmic diseases, such as glaucoma, cataract, and other vision-related issues.
Asia-Pacific Ophthalmology Lasers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
-
Increasing incidences of chronic and communicable eye diseases
The field of ophthalmology has seen a rise in the incidence of both chronic and communicable eye diseases in recent years. Some of the major factors contributing to this trend include a growing Asia-Pacific population, an aging population, increased urbanization, changing lifestyles, and increased exposure to environmental pollutants. One of the most common chronic eye diseases is Age-Related Macular Degeneration (AMD). AMD is a leading cause of blindness in people over the age of 60 and is caused by damage to the macula, a small part of the retina responsible for central vision. The prevalence of AMD is expected to increase with an aging Asia-Pacific population. Another chronic eye disease that is becoming more prevalent is glaucoma. Glaucoma is a group of eye diseases that cause damage to the optic nerve and can lead to blindness. It is often asymptomatic until it reaches an advanced stage, making regular eye exams crucial for early detection and treatment.
In March 2023, according to an article by Indian Express, Asia-Pacific, glaucoma is the second leading cause of blindness after cataracts. It is estimated to cause blindness in 4.5 million people worldwide. Despite this, glaucoma is largely undiagnosed, with more than 90 percent of untreated cases. Thus, increasing incidences of chronic and communicable eye diseases are expected to drive the market's growth.
-
Increased consumer awareness for laser treatments
Consumer awareness of laser therapies has increased, which has benefited the market for ophthalmic lasers Asia-Pacific. Several factors have contributed to this trend, including advancements in technology, increased access to information, and greater emphasis on patient education. One of the main drivers of increased consumer awareness is the development of new laser systems that offer improved precision, reduced recovery times, and better outcomes. These systems have been shown to be effective in treating a range of eye conditions, from refractive errors to more complex retinal disorders. Patients are increasingly interested in these treatments and are seeking out ophthalmologists who are trained to use them. Another factor contributing to increased awareness is the availability of information about ophthalmology lasers. Patients can easily access information online about the different types of laser treatments available, their benefits, and potential risks. This has helped to demystify laser treatments and make them more accessible to a wider range of patients which is expected to drive the market's growth.
-
Increasing adoption of outpatient procedures
The field of ophthalmology has seen significant advancements in recent years with the advent of laser technology. With the increasing adoption of outpatient procedures, the Asia-Pacific ophthalmology lasers market presents a significant opportunity for growth. Outpatient procedures are medical procedures that do not require an overnight stay in a hospital. These procedures can be performed in a medical office, ambulatory surgery center, or outpatient clinic. Thus, the increasing adoption of outpatient procedures is expected to drive the market's growth.
Opportunities
-
Technological advancements in ophthalmology
Technological advancements in the field of ophthalmology have revolutionized the diagnosis, treatment, and management of various eye diseases and conditions. These advancements have created significant opportunities in the Asia-Pacific ophthalmology lasers market, with the potential to improve patient outcomes, increase efficiency, and drive growth in the industry. One of the most significant technological advancements in ophthalmology has been the development of femtosecond lasers. These lasers are used for precision surgeries and can create incisions that are more precise and predictable than those created by traditional surgical tools. This technology has revolutionized procedures such as photocoagulation lasers, Selective Laser Trabeculoplasty (SLT), allowing for faster recovery times and better visual outcomes, which is expected to provide a lucrative opportunity for the market's growth.
Restraints/Challenges
- Lack of skilled professionals
Ophthalmology lasers are used in various procedures, including refractive surgeries, cataract surgeries, and glaucoma treatment. However, the effective use of these lasers requires skilled professionals who are proficient in handling them. The lack of such professionals can lead to errors, complications, and adverse outcomes, which can harm patients and damage the industry's reputation.
The main reason for the shortage of skilled professionals is the complexity of the equipment and the procedures involved. Ophthalmology lasers require specialized knowledge and expertise, and the training required to become proficient in using them can be time-consuming and expensive. In addition, the procedures themselves are often intricate and require a high level of skill and precision
Hence, a lack of skilled professionals will impede the growth rate of the ophthalmology lasers market. Additionally, stringent rules and regulations will further challenge the market in the forecast period.
Recent Development
- In November 2022, Alcon, the Asia-Pacific leader in eye care dedicated to helping people see brilliantly, announced that it had completed its acquisition of Aerie Pharmaceuticals, Inc. This transaction helps bolster Alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
- In March 2023, Bausch + Lomb Corporation and Novaliq GmbH announced that the American Journal of Ophthalmology had published results from MOJAVE, the second pivotal Phase 3 trial for NOV03 (perfluorohexyloctane). NOV03 is being investigated to treat the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). Results from the first pivotal Phase 3 trial, GOBI, were published earlier this year in the American Journal of Ophthalmology.
Asia-Pacific Ophthalmology Lasers Market Scope
The Asia-Pacific ophthalmology lasers market is segmented into product, type, application, gases, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Femtosecond Lasers
- Excimer Lasers
- Nd: YAG Lasers
- Diode Lasers
- Others
On the basis of product, the market is segmented into femtosecond lasers, excimer lasers, Nd: YAG lasers, diode lasers, and others.
Type
- Photodisruption Lasers
- Selective Laser Trabeculoplasty (SLT)
- Photocoagulation Lasers
On the basis of type, the market is segmented into photodisruption lasers, selective laser trabeculoplasty (SLT), and photocoagulation lasers.
Application
- Diagnostics
- Therapeutics
On the basis of application, the market is segmented into diagnostics and therapeutics.
Gases
- Noble gas
- Halogen gas
- Buffer gas
- Others
On the basis of gases, the market is segmented into noble gas, halogen gas, buffer gas, and others.
End User
- Hospitals
- Clinics
- Others
On the basis of end user, the market is segmented into hospitals, clinics, and others.
Asia-Pacific Ophthalmology Lasers Market Regional Analysis/Insights
The Asia-Pacific ophthalmology lasers market is analyzed, and market size insights and trends are provided by country, product, type, application, gases, and end user, as referenced above.
The countries covered in the Asia-Pacific ophthalmology lasers market are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and the rest of Asia-Pacific.
Japan is expected to dominate the ophthalmology lasers market in the Asia-Pacific region in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of ophthalmic disorders in the region, and rapid research development is boosting the market.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Asia-Pacific brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Ophthalmology Lasers Market Share Analysis
The Asia-Pacific ophthalmology lasers market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Asia-Pacific ophthalmology lasers market.
Some of the major players operating in the Asia-Pacific ophthalmology lasers market are NIDEK CO., LTD., Quantel Medical (Subsidiary of Lumibird Medical), Aurolab, Alcon, Ziemer Ophthalmic Systems AG, LIGHTMED, Johnson & Johnson Inc., Bausch & Lomb Incorporated, MEDA Co., Ltd., Topcon, Lumenis Be Ltd., IRIDEX Corporation, and Zeiss among others.
SKU-